BEIJING,Nov. 19,2024-- With the support of the RiDYMO® platform,we are able to comprehensively explore various potential targets in drug development,including protein-protein interactions,kinases,
News
The investment will initially focus on expediting development at existing sites inNavi Mumbai and Ambattur,Chennai,with an additional third site to be added in future.
11-20
Pop Culture Announces Improvement in Overall Operations During the Fiscal Year Ended June 30, 2024XIAMEN,China,Nov. 19,2024-- In the fiscal year ended June 30,2024,POP CULTURE GROUP CO.,LTD. ("Pop Culture," or the "Company," Nasdaq: CPOP) continued to focus on its three busines
48-week end-of-treatment data from theongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα
Database pioneer continues to scale at $2B+ valuation as GenAI accelerates demand SAN MATEO,Calif.,Nov. 19,2024--Neo4j®,the world\'s leading graph database and analytics company,announced that it
11-20
Ractigen Therapeutics Announces FDA Orphan Drug Designation for RAG-21 for the Treatment of ALSNANTONG and SUZHOU,China,Nov. 19,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing innovative therapies,today announced that the U.S. Food and Drug Administr
GUANGZHOU,China,Nov. 19,2024-- On November 16th,the 2024 TCL CSOT Global Display Tech-ecosystem Conference (DTC2024) kicked off with great fanfare. The event brought together display industry experts,
LOS ANGELES,Nov. 19,2024-- Quinn Emanuel filed a lawsuit today in California against Anthony ("Tony") Buzbeefor extortion based on Buzbee\'s threats of publicizing false information for fin
This expansion will bring new opportunities for local talent and boost the digital economy HONG KONG,Nov. 15,2024-- Oxygen,a leading HubSpot Solutions Partner and CRM implementation specialist,has ope
